Crane Advisory’s Medtronic MDT Stock Holding History

Crane Advisory’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,499	Closed	-$210K	–	42
2024 Q1	$210K	Sell	2,499 -369	-13%	-$31.5K	0.04%	39
2023 Q4	$243K	Hold	2,868	–	–	0.05%	31
2023 Q3	$215K	Hold	2,868	–	–	0.05%	27
2023 Q2	$249K	Hold	2,868	–	–	0.07%	27
2023 Q1	$232K	Buy	+2,868	New	+$234K	0.08%	23

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Crane Advisory's MDT Position: Q2 2024 in Review

Crane Advisory sold out of Medtronic (MDT) in Q2 2024, closing a stake of 2,499 shares — an estimated $210K sold.

Crane Advisory first reported a position in MDT in Q1 2023 and held it in 5 quarters. The position peaked at $249K in Q2 2023. 2,029 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

Crane Advisory reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
Crane Advisory sold 2,499 Medtronic shares in Q2 2024, an estimated $210K.
Crane Advisory first reported a position in Medtronic in Q1 2023 and held it in 5 quarters.
Crane Advisory's Medtronic position peaked at $249K in Q2 2023.
2,029 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Crane Advisory's 13F filing for Q2 2024, filed 12 Jul 2024.